IBDEI0IK ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,8351,1,4,0)
;;=4^B37.42
;;^UTILITY(U,$J,358.3,8351,2)
;;=^5000617
;;^UTILITY(U,$J,358.3,8352,0)
;;=A59.03^^39^398^110
;;^UTILITY(U,$J,358.3,8352,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8352,1,3,0)
;;=3^Trichomonal Cystitis & Urethritis
;;^UTILITY(U,$J,358.3,8352,1,4,0)
;;=4^A59.03
;;^UTILITY(U,$J,358.3,8352,2)
;;=^5000349
;;^UTILITY(U,$J,358.3,8353,0)
;;=E87.6^^39^398^63
;;^UTILITY(U,$J,358.3,8353,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8353,1,3,0)
;;=3^Hypokalemia
;;^UTILITY(U,$J,358.3,8353,1,4,0)
;;=4^E87.6
;;^UTILITY(U,$J,358.3,8353,2)
;;=^60610
;;^UTILITY(U,$J,358.3,8354,0)
;;=F52.0^^39^398^62
;;^UTILITY(U,$J,358.3,8354,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8354,1,3,0)
;;=3^Hypoactive Sexual Desire Disorder
;;^UTILITY(U,$J,358.3,8354,1,4,0)
;;=4^F52.0
;;^UTILITY(U,$J,358.3,8354,2)
;;=^5003618
;;^UTILITY(U,$J,358.3,8355,0)
;;=F52.22^^39^398^105
;;^UTILITY(U,$J,358.3,8355,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8355,1,3,0)
;;=3^Sexual Arousal Disorder,Female
;;^UTILITY(U,$J,358.3,8355,1,4,0)
;;=4^F52.22
;;^UTILITY(U,$J,358.3,8355,2)
;;=^5003621
;;^UTILITY(U,$J,358.3,8356,0)
;;=F52.8^^39^398^106
;;^UTILITY(U,$J,358.3,8356,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8356,1,3,0)
;;=3^Sexual Dysfnct Not d/t Substance/Known Physiological Cond
;;^UTILITY(U,$J,358.3,8356,1,4,0)
;;=4^F52.8
;;^UTILITY(U,$J,358.3,8356,2)
;;=^5003624
;;^UTILITY(U,$J,358.3,8357,0)
;;=F52.21^^39^398^35
;;^UTILITY(U,$J,358.3,8357,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8357,1,3,0)
;;=3^Erectile Disorder,Male (Psychogenic)
;;^UTILITY(U,$J,358.3,8357,1,4,0)
;;=4^F52.21
;;^UTILITY(U,$J,358.3,8357,2)
;;=^5003620
;;^UTILITY(U,$J,358.3,8358,0)
;;=I12.9^^39^398^61
;;^UTILITY(U,$J,358.3,8358,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8358,1,3,0)
;;=3^Hypertensive Kidney Disease Chronic w/ Stg 1-4
;;^UTILITY(U,$J,358.3,8358,1,4,0)
;;=4^I12.9
;;^UTILITY(U,$J,358.3,8358,2)
;;=^5007066
;;^UTILITY(U,$J,358.3,8359,0)
;;=N04.9^^39^398^78
;;^UTILITY(U,$J,358.3,8359,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8359,1,3,0)
;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
;;^UTILITY(U,$J,358.3,8359,1,4,0)
;;=4^N04.9
;;^UTILITY(U,$J,358.3,8359,2)
;;=^5015540
;;^UTILITY(U,$J,358.3,8360,0)
;;=N02.9^^39^398^55
;;^UTILITY(U,$J,358.3,8360,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8360,1,3,0)
;;=3^Hematuria w/ Unspec Morphologic Changes,Recurrent & Persistent
;;^UTILITY(U,$J,358.3,8360,1,4,0)
;;=4^N02.9
;;^UTILITY(U,$J,358.3,8360,2)
;;=^5015520
;;^UTILITY(U,$J,358.3,8361,0)
;;=N06.9^^39^398^95
;;^UTILITY(U,$J,358.3,8361,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8361,1,3,0)
;;=3^Proteinuria Isolated w/ Unspec Morphologic Lesion
;;^UTILITY(U,$J,358.3,8361,1,4,0)
;;=4^N06.9
;;^UTILITY(U,$J,358.3,8361,2)
;;=^5015558
;;^UTILITY(U,$J,358.3,8362,0)
;;=N05.9^^39^398^75
;;^UTILITY(U,$J,358.3,8362,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8362,1,3,0)
;;=3^Nephritic Syndrome w/ Unspec Morphologic Changes
;;^UTILITY(U,$J,358.3,8362,1,4,0)
;;=4^N05.9
;;^UTILITY(U,$J,358.3,8362,2)
;;=^5134086
;;^UTILITY(U,$J,358.3,8363,0)
;;=N07.9^^39^398^77
;;^UTILITY(U,$J,358.3,8363,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8363,1,3,0)
;;=3^Nephropathy Hereditary w/ Unspec Morphologic Lesions
;;^UTILITY(U,$J,358.3,8363,1,4,0)
;;=4^N07.9
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0IK 3770 printed Sep 23, 2025@19:25:22 Page 2
IBDEI0IK ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,8351,1,4,0)
+2 ;;=4^B37.42
+3 ;;^UTILITY(U,$J,358.3,8351,2)
+4 ;;=^5000617
+5 ;;^UTILITY(U,$J,358.3,8352,0)
+6 ;;=A59.03^^39^398^110
+7 ;;^UTILITY(U,$J,358.3,8352,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,8352,1,3,0)
+10 ;;=3^Trichomonal Cystitis & Urethritis
+11 ;;^UTILITY(U,$J,358.3,8352,1,4,0)
+12 ;;=4^A59.03
+13 ;;^UTILITY(U,$J,358.3,8352,2)
+14 ;;=^5000349
+15 ;;^UTILITY(U,$J,358.3,8353,0)
+16 ;;=E87.6^^39^398^63
+17 ;;^UTILITY(U,$J,358.3,8353,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,8353,1,3,0)
+20 ;;=3^Hypokalemia
+21 ;;^UTILITY(U,$J,358.3,8353,1,4,0)
+22 ;;=4^E87.6
+23 ;;^UTILITY(U,$J,358.3,8353,2)
+24 ;;=^60610
+25 ;;^UTILITY(U,$J,358.3,8354,0)
+26 ;;=F52.0^^39^398^62
+27 ;;^UTILITY(U,$J,358.3,8354,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,8354,1,3,0)
+30 ;;=3^Hypoactive Sexual Desire Disorder
+31 ;;^UTILITY(U,$J,358.3,8354,1,4,0)
+32 ;;=4^F52.0
+33 ;;^UTILITY(U,$J,358.3,8354,2)
+34 ;;=^5003618
+35 ;;^UTILITY(U,$J,358.3,8355,0)
+36 ;;=F52.22^^39^398^105
+37 ;;^UTILITY(U,$J,358.3,8355,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,8355,1,3,0)
+40 ;;=3^Sexual Arousal Disorder,Female
+41 ;;^UTILITY(U,$J,358.3,8355,1,4,0)
+42 ;;=4^F52.22
+43 ;;^UTILITY(U,$J,358.3,8355,2)
+44 ;;=^5003621
+45 ;;^UTILITY(U,$J,358.3,8356,0)
+46 ;;=F52.8^^39^398^106
+47 ;;^UTILITY(U,$J,358.3,8356,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,8356,1,3,0)
+50 ;;=3^Sexual Dysfnct Not d/t Substance/Known Physiological Cond
+51 ;;^UTILITY(U,$J,358.3,8356,1,4,0)
+52 ;;=4^F52.8
+53 ;;^UTILITY(U,$J,358.3,8356,2)
+54 ;;=^5003624
+55 ;;^UTILITY(U,$J,358.3,8357,0)
+56 ;;=F52.21^^39^398^35
+57 ;;^UTILITY(U,$J,358.3,8357,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,8357,1,3,0)
+60 ;;=3^Erectile Disorder,Male (Psychogenic)
+61 ;;^UTILITY(U,$J,358.3,8357,1,4,0)
+62 ;;=4^F52.21
+63 ;;^UTILITY(U,$J,358.3,8357,2)
+64 ;;=^5003620
+65 ;;^UTILITY(U,$J,358.3,8358,0)
+66 ;;=I12.9^^39^398^61
+67 ;;^UTILITY(U,$J,358.3,8358,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,8358,1,3,0)
+70 ;;=3^Hypertensive Kidney Disease Chronic w/ Stg 1-4
+71 ;;^UTILITY(U,$J,358.3,8358,1,4,0)
+72 ;;=4^I12.9
+73 ;;^UTILITY(U,$J,358.3,8358,2)
+74 ;;=^5007066
+75 ;;^UTILITY(U,$J,358.3,8359,0)
+76 ;;=N04.9^^39^398^78
+77 ;;^UTILITY(U,$J,358.3,8359,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,8359,1,3,0)
+80 ;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
+81 ;;^UTILITY(U,$J,358.3,8359,1,4,0)
+82 ;;=4^N04.9
+83 ;;^UTILITY(U,$J,358.3,8359,2)
+84 ;;=^5015540
+85 ;;^UTILITY(U,$J,358.3,8360,0)
+86 ;;=N02.9^^39^398^55
+87 ;;^UTILITY(U,$J,358.3,8360,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,8360,1,3,0)
+90 ;;=3^Hematuria w/ Unspec Morphologic Changes,Recurrent & Persistent
+91 ;;^UTILITY(U,$J,358.3,8360,1,4,0)
+92 ;;=4^N02.9
+93 ;;^UTILITY(U,$J,358.3,8360,2)
+94 ;;=^5015520
+95 ;;^UTILITY(U,$J,358.3,8361,0)
+96 ;;=N06.9^^39^398^95
+97 ;;^UTILITY(U,$J,358.3,8361,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,8361,1,3,0)
+100 ;;=3^Proteinuria Isolated w/ Unspec Morphologic Lesion
+101 ;;^UTILITY(U,$J,358.3,8361,1,4,0)
+102 ;;=4^N06.9
+103 ;;^UTILITY(U,$J,358.3,8361,2)
+104 ;;=^5015558
+105 ;;^UTILITY(U,$J,358.3,8362,0)
+106 ;;=N05.9^^39^398^75
+107 ;;^UTILITY(U,$J,358.3,8362,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,8362,1,3,0)
+110 ;;=3^Nephritic Syndrome w/ Unspec Morphologic Changes
+111 ;;^UTILITY(U,$J,358.3,8362,1,4,0)
+112 ;;=4^N05.9
+113 ;;^UTILITY(U,$J,358.3,8362,2)
+114 ;;=^5134086
+115 ;;^UTILITY(U,$J,358.3,8363,0)
+116 ;;=N07.9^^39^398^77
+117 ;;^UTILITY(U,$J,358.3,8363,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,8363,1,3,0)
+120 ;;=3^Nephropathy Hereditary w/ Unspec Morphologic Lesions
+121 ;;^UTILITY(U,$J,358.3,8363,1,4,0)
+122 ;;=4^N07.9
